Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment.
Shaoxian WuHao HuangRunzi SunDavid Shihong GaoFan YeJianing HuangElla LiAndrew NiKevin GuoKai LuKong ChenJing Ting JiangPenelope A MorelZiyang ZhongBinfeng LuPublished in: Cancer research communications (2023)
This study reveals how cytokine and checkpoint inhibitor therapy can be combined to increase the efficacy of cancer immunotherapy.